PATENT CLAIM ANALYSIS

Application Number: 15876086
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "094610"]

Abstract:
Methods of treating glycogen storage disease type II, by administering acid α-glucosidase, are described, as are compositions for use in treatment of glycogen storage disease type II.

Claim (Index 1):
A method of treating glycogen storage disease type II in a human individual having glycogen storage disease type II, comprising administering to the individual a therapeutically effective amount of a precursor form of human acid \u03b1-glucosidase produced in Chinese hamster ovary cell culture (CHO GAA) at a regular interval, wherein said precursor form is administered in conjunction with an immunosuppressive or immunotherapeutic regimen, and wherein said immunosuppressive or immunotherapeutic regimen is administered prior to any administration of said precursor form.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.40909
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13593148', '15066211', '14485071', '09902461', '12737394']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6657588389977109
- 35 USC 102 Novelty (BERT): 0.5449925657651561
- Combined Prediction Score: 0.6536822116744554
- Mean Citation Score: 366.296622
- Max Citation Score: 383.0992
- Similarity Product: 330.51408285093305

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test